Amir Ansaripour
Rotterdam, ZH 3032AC, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials.
Journal: Frontiers in neurology
Published: August 14, 2024
Digital variance angiography in patients undergoing lower limb arterial recanalization: cost-effectiveness analysis within the English healthcare setting.
Journal: Journal of comparative effectiveness research
Published: March 22, 2024
Cost-effectiveness analysis of Avance® allograft for the treatment of peripheral nerve injuries in the USA.
Journal: Journal of comparative effectiveness research
Published: November 30, 2023
Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis.
Journal: PharmacoEconomics - open
Published: August 24, 2022
Budget Impact of the Vest™ High Frequency Chest Wall Oscillation System for Managing Airway Clearance in Patients with Complex Neurological Disorders: A US Healthcare Payers' Perspective Analysis.
Journal: PharmacoEconomics - open
Published: August 08, 2021
Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan.
Journal: Current medical research and opinion
Published: April 16, 2021
Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: June 10, 2020
Severity-Adjusted Probability of Being Cost Effective.
Journal: PharmacoEconomics
Published: May 28, 2019
Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.
Journal: PharmacoEconomics
Published: February 25, 2018
Response to 'Comment on ''Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy"'.
Journal: PharmacoEconomics
Published: February 11, 2018
Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.
Journal: PharmacoEconomics
Published: August 11, 2017
The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis.
Journal: Journal of comparative effectiveness research
Published: April 29, 2017
Last Updated: 09/26/2026